Issue Date: January 12, 2009
Broad Scientists Launch Biotech
Three scientists from the Broad Institute of MIT and Harvard University—Stuart L. Schreiber, Todd R. Golub, and Michael A. Foley—have joined forces to launch Forma Therapeutics, a drug firm focused on discovering drugs that act against challenging cancer targets. Cambridge, Mass.-based Forma will employ a cell-based screening platform to identify targets and will then apply structure-based drug discovery methods to design and optimize molecules to interact with those targets. The start-up has received $25 million in funding from the Novartis Option Fund, the investment arm of the Swiss drug giant, and Bio*One Capital, of Singapore.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society